These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26334051)

  • 1. Editorial Commentary: Keeping Our Eyes on the Prize: No New HIV Infections With Increased Use of HIV Pre-exposure Prophylaxis.
    Koester KA; Grant RM
    Clin Infect Dis; 2015 Nov; 61(10):1604-5. PubMed ID: 26334051
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial Commentary: Scaling Up Antiretroviral Preexposure Prophylaxis: Moving From Trials to Implementation.
    Mayer KH; Krakower DS
    Clin Infect Dis; 2015 Nov; 61(10):1598-600. PubMed ID: 26270688
    [No Abstract]   [Full Text] [Related]  

  • 3. No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting.
    Volk JE; Marcus JL; Phengrasamy T; Blechinger D; Nguyen DP; Follansbee S; Hare CB
    Clin Infect Dis; 2015 Nov; 61(10):1601-3. PubMed ID: 26334052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PrEP Continuum of Care for MSM in Atlanta and Los Angeles County.
    Joseph Davey D; Bustamante MJ; Wang D; Young S; Klausner JD
    Clin Infect Dis; 2016 Feb; 62(3):402-3. PubMed ID: 26486706
    [No Abstract]   [Full Text] [Related]  

  • 5. Decline in new HIV diagnoses among MSM in Melbourne.
    Chow EPF; Medland NA; Denham I; Wright EJ; Fairley CK
    Lancet HIV; 2018 Sep; 5(9):e479-e481. PubMed ID: 30215345
    [No Abstract]   [Full Text] [Related]  

  • 6. Interview With Jean-Daniel Lelièvre, PU-PH, Head of the Research Clinic of the VRI (Vaccine Research Institute).
    Lelievre JD; Ollivier-Yaniv C
    J Acquir Immune Defic Syndr; 2018 Oct; 79 Suppl 1():S8-S12. PubMed ID: 30222700
    [No Abstract]   [Full Text] [Related]  

  • 7. Promise and pitfalls of pre-exposure prophylaxis for female sex workers.
    Cowan FM; Delany-Moretlwe S
    Curr Opin HIV AIDS; 2016 Jan; 11(1):27-34. PubMed ID: 26633639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV sexual transmission and microbicides.
    Ariën KK; Jespers V; Vanham G
    Rev Med Virol; 2011 Mar; 21(2):110-33. PubMed ID: 21412935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes.
    Wang X; Nwokolo N; Korologou-Linden R; Hill A; Whitlock G; Day-Weber I; McClure MO; Boffito M
    HIV Med; 2018 Jan; 19(1):1-6. PubMed ID: 28657199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highlights of HIVR4P 2018.
    Zuccala E
    Lancet HIV; 2018 Dec; 5(12):e683. PubMed ID: 30527326
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial Commentary: Unmasking the Bare Bones of HIV Preexposure Prophylaxis.
    Falutz J
    Clin Infect Dis; 2015 Aug; 61(4):581-3. PubMed ID: 25908681
    [No Abstract]   [Full Text] [Related]  

  • 12. Planning for HIV preexposure prophylaxis introduction: lessons learned from contraception.
    Delany-Moretlwe S; Mullick S; Eakle R; Rees H
    Curr Opin HIV AIDS; 2016 Jan; 11(1):87-93. PubMed ID: 26575146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying a PrEP Continuum of Care for Men Who Have Sex With Men in Atlanta, Georgia.
    Kelley CF; Kahle E; Siegler A; Sanchez T; Del Rio C; Sullivan PS; Rosenberg ES
    Clin Infect Dis; 2015 Nov; 61(10):1590-7. PubMed ID: 26270691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-Exposure Prophylaxis for HIV Prevention.
    Fadul N
    N C Med J; 2016; 77(5):361-2. PubMed ID: 27621351
    [No Abstract]   [Full Text] [Related]  

  • 15. Rethinking HIV pre-exposure prophylaxis prevention strategy.
    Kistan J; Serwadda D
    Lancet HIV; 2016 Apr; 3(4):e155-7. PubMed ID: 27036990
    [No Abstract]   [Full Text] [Related]  

  • 16. Offering pre-exposure prophylaxis for HIV prevention to pregnant and postpartum women: a clinical approach.
    Seidman DL; Weber S; Cohan D
    J Int AIDS Soc; 2017 Mar; 20(Suppl 1):21295. PubMed ID: 28361503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical issues in trials of preexposure prophylaxis.
    Dunn DT; Glidden DV
    Curr Opin HIV AIDS; 2016 Jan; 11(1):116-21. PubMed ID: 26545264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What does preexposure prophylaxis mean for treatment; what does treatment mean for preexposure prophylaxis?
    Venter WD
    Curr Opin HIV AIDS; 2016 Jan; 11(1):35-40. PubMed ID: 26545265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polarised press reporting about HIV prevention: Social representations of pre-exposure prophylaxis in the UK press.
    Jaspal R; Nerlich B
    Health (London); 2017 Sep; 21(5):478-497. PubMed ID: 27216725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-Exposure Prophylaxis as a Method for Prevention of Human Immunodeficiency Virus Infection.
    Elbirt D; Mahlab-Guri K; Bezalel-Rosenberg S; Asher I; Sthoeger Z
    Isr Med Assoc J; 2016 May; 18(5):294-8. PubMed ID: 27430088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.